Background: Most people with depression do not achieve adequate treatment response. People’s perceptions of their depression and treatment outcomes are crucial to understanding challenges...
Background: An open-label extension study (NCT02873208) evaluated the long-term tolerability, safety, and efficacy of combination olanzapine/samidorphan (OLZ/SAM) treatment in patients wi...
Background: Oral antipsychotic medications (OAMs) are frequently prescribed to patients with bipolar I disorder (BD-1) for symptom control. A cross-sectional survey examined side effects ...